Dr. James H. Frederich, Assistant Professor

Professional Preparation/Appointments

B.S. University of Oregon (2005)
Ph.D. UC Irvine (2011)
Postdoc, UCLA (2011-2014)

Contact Information

Email jfrederich@fsu.edu
Office 5009 CSL 850.645.0989
Lab 5401 CSL 850.645.0988

Programs of Research


Research Specialties

Synthesis and Catalysis, Chemical Biology

Research Interest

Natural products provide a rich source of pharmaceutical drug leads. Inspired by the application(s) of secondary metabolites in understanding and treating human disease, research in the Frederich Laboratory focuses on developing new strategies and tactics to prepare architecturally complex natural products that exhibit important biological activity in living systems. A critical aspect of this endeavor involves the design of new reactions that build molecular complexity, thereby allowing us to approach challenging structures in a practical way. Longer-term, access to our targets opens up new avenues to explore their pharmacology. At this stage, exercises in molecular biology, biophysics, and medicinal chemistry become part of interdisciplinary research aimed at identifying new drug targets and developing prototype therapeutics. 


Click to View

Sengupta, A.; Liriano, J.; Miller, B. G.; Frederich, J. H. Analysis of interactions stabilized by fusicoccin A reveals an expand suite of potential 14-3-3 binding partners. ACS Chem. Bio. 2020 (in press).

Borger, M.; Frederich, J. H. Pyridazine N-oxides as precursors to 2-aminofurans: Scope and limitations in complexity building cascade reactions. Org. Lett. 2019, 21, 2397.

Salvait, A. E.; Law, J. A.; Liriano, J.; Frederich, J. H. Modular access to functionalized 5-8-5 ring systems via a photoinduced cycloisomerization reaction. Chem. Sci. 2018, 9, 5389.

Portillo, M; Maxwell, M. A.; Frederich, J. H. Synthesis of nitrogen heterocycles via photochemical ring opening of pyridazine N-oxides. Org. Lett. 2016, 18, 5142.

Frederich, J. H.; Harran. P. G. Modular access to complex prodiginines: Total synthesis of (+)-roseophilin via its 2-azafulvene prototropisomer. J. Am. Chem. Soc. 2013, 135, 3788.